Back to Resource Hub White paper

The Role of Patient Engagement in Clinical Research

The COVID-19 pandemic fundamentally altered how clinical trials operate, creating significant uncertainty for patients about their treatment continuity, visit schedules, and potential health risks.

Patient engagement solutions emerged as critical lifelines for maintaining research continuity.

This paper explains how integrated mobile applications like our Patient Engagement solution, built into SmartSignals eCOA, enabled sponsors to provide real-time study updates, rescheduling information, prescreening tools for COVID-19 symptoms, and retention programming that kept participants connected despite physical isolation.

Video technology has proven particularly transformative, allowing trial continuity during COVID and reducing unnecessary site visits. When integrated within comprehensive engagement platforms, virtual visits create seamless transitions from in-person to remote interactions without disrupting the critical patient-clinician relationship.

Read the paper to learn how to transform patient experience with our integrated patient engagement platform.

Similar posts

Looking for more insights? Explore related resources.

WHITE PAPER

The Use of Data 
Analytics During the 
COVID-19 Pandemic

READ THE PAPER
VIDEO

Leadership Perspectives: Our Focus on Patients & Sites in Clinical Trials

WATCH THE VIDEO
WHITE PAPER

Remote Ratings as an 
Adaptation to COVID-19

READ THE PAPER

Get notified on new marketing insights

Here mention the benefits of subscribing